16930 Investors following Glenmark. Share this News with them.
0
Like this story, share it with millions of investors on M3
Glenmark files for USFDA ph-1 trials for GBR 500 BE
Glenmark hopes for at least two out of three molecules to go into clinical pahse-1 in FY09, reports CNBC-TV18. The company is filing for USFDA phase-1 trials for GBR 500 biological entity. Glenmark will close two out-licensing deals for molecules by March 2009.
